
BAVENCIO® (avelumab) For Healthcare Professionals
Discover BAVENCIO® (avelumab) for the treatment of metastatic Merkel cell carcinoma & first-line maintenance treatment for metastatic urothelial carcinoma.
BAVENCIO® Patient
BAVENCIO is a prescription medicine used to treat: a type of skin cancer called Merkel cell carcinoma (MCC) in adults and children 12 years of age and older. BAVENCIO may be used when your skin cancer has spread
BAVENCIO(avelumab)is indicated for the treatment of adultsand pediatric patients 12years and older with metastatic Merkel cell carcinoma (MCC). This indication is approved under accelerated approvalbased on tumor response and duration of
Locally Advanced or Metastatic UC | BAVENCIO® (avelumab) For …
Learn about BAVENCIO® (avelumab) as the first and only immunotherapy approved for the first-line maintenance treatment of metastatic urothelial carcinoma. Learn more
About BAVENCIO® (avelumab) – For metastatic Merkel cell …
BAVENCIO is a prescription medicine used to treat a type of skin cancer called Merkel cell carcinoma (MCC) in adults and children 12 years of age and older. BAVENCIO may be used when your skin cancer has spread.
BAVENCIO is the first medicine that the Food and Drug Administration (FDA) approved to treat metastatic MCC in adults and children ages 12 and older. BAVENCIO is a man-made antibody. Your body naturally produces antibodies to help your immune system work. BAVENCIO is delivered by an intravenous (IV) infusion directly into your bloodstream.
• BAVENCIO is a monoclonal antibody that belongs to a class of drugs that bind to either the programmed death-receptor 1 (PD-1) or the PD-ligand 1 (PD-L1), blocking the PD-1/PD-L1 pathway, thereby removing inhibition of the immune response, potentially
Mechanism of Action | BAVENCIO® (avelumab) For HCPs
Find the BAVENCIO® (avelumab) mechanism of action. Explore how BAVENCIO® a PD-L1 inhibitor activates dual immune function. Learn more
Patient Profiles | BAVENCIO® (avelumab) For HCPs
Find the BAVENCIO® (avelumab) safety profile, including adverse reactions & dose modifications for locally advanced or metastatic urothelial carcinoma.
Taking Bavencio
BAVENCIO ® (avelumab) is a medicine that may treat certain cancers by working with your immune system. BAVENCIO can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way they work. These problems can sometimes become severe or life-threatening and can lead to death.